6 Results for "

glutamine transaminase

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "glutamine transaminase" in MCE Product Catalog:

Cat. No.: HY-W170255
CAS No.: 10255-67-1
Sodium mercaptopyruvate serves as a substrate for Lactate dehydrogenase and Sulfurtransferase. Sodium mercaptopyruvate forms through enzymatic transamination and oxidative deamination of L-cysteine (HY-Y0337). Sodium mercaptopyruvate abolishes lactate dehydrogenase reaction activity. It increases urinary thiosulfate excretion, fails to sustain rat growth by replacing L-cystine (HY-N0394), and does not induce morbidity or mortality in mice. Sodium mercaptopyruvate is applicable to research related to 3-mercaptopyruvate disulfiduria and 3-mercaptolactate disulfiduria .
loading...
    loading...
Cat. No.: HY-P76359
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: GFPT1; GFAT 1; Prev. GFPT; glutamine--Fructose-6-Phosphate transaminase (Isomerizing); GFAT1; glutamine-Fructose-6-Phosphate transaminase 1; GFAT; CMSTA1; GFA; GFAT1m; glutamine--Fructose-6-Phosphate Aminotransferase [Isomerizing] 1; GFPT1L; glutamine:Fru
Species:  
Human
Source:  
E. coli
loading...
    loading...
Cat. No.: HY-P71533
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: KYAT1; Cysteine-S-Conjugate Beta-Lyase; Prev. CCBL1; Kynurenine--Oxoglutarate transaminase I; glutamine--Phenylpyruvate transaminase; Cysteine Conjugate Beta Lyase 1; Kynurenine Aminotransferase I; Cysteine Conjugate-Beta Lyase, Cytoplasmic; glutamine Tra
Species:  
Human
Source:  
E. coli
loading...
    loading...
Cat. No.: HY-E71382
Research Areas:  

Others

1D-1-Guanidino-3-amino-1,3-dideoxy-scyllo-inositol transaminase (EC 2.6.1.56): l-Glutamate and L-glutamine can also act as amino donors.
loading...
    loading...
Cat. No.: HY-L064
1,827 compounds

Glutamine is an important metabolic fuel that helps rapidly proliferating cells meet the increased demand for ATP, biosynthetic precursors, and reducing agents. Glutamine Metabolism pathway involves the initial deamination of glutamine by glutaminase(GLS), yielding glutamate and ammonia. Glutamate is converted to the TCA cycle intermediate α-ketoglutarate (α-KG) by either glutamate dehydrogenase (GDH) or by the alanine or aspartate transaminases (TAs), to produce both ATP and anabolic carbons for the synthesis of amino acids, nucleotides and lipids. During periods of hypoxia or mitochondrial dysfunction, α-KG can be converted to citrate in a reductive carboxylation reaction catalyzed by IDH2. The newly formed citrate exits the mitochondria where it is used to synthesize fatty acids and amino acids and produce the reducing agent, NADPH.

Cancer cells display an altered metabolic circuitry that is directly regulated by oncogenic mutations and loss of tumor suppressors. Mounting evidence indicates that altered glutamine metabolism in cancer cells has critical roles in supporting macromolecule biosynthesis, regulating signaling pathways, and maintaining redox homeostasis, all of which contribute to cancer cell proliferation and survival. Thus, intervention in glutamine metabolic processes could provide novel approaches to improve cancer treatment.

MCE owns a unique collection of 1,827 compounds targeting the mainly proteins and enzymes involved in glutamine metabolism pathway. Glutamine Metabolism compound library is a useful tool for intervention in glutamine metabolic processes.

Cat. No.: HY-N14093
CAS No.: 57744-69-1
Aspulvinone H is an orally active inhibitor of AChE, pancreatic lipase, glutamic-oxaloacetic transaminase 1, and α-glucosidase, with IC50 values of 25.95 μM, 47.06 μM, 5.91/6.91 μM, and 4.6 μM, respectively. It has a Ka of 2.14 μM against GOT1 and a Ki of 6.58 μM against α-glucosidase. Aspulvinone H inhibits cancer cell proliferation, interferes with glutamine metabolism, elevates ROS levels, and induces cell apoptosis and S-phase arrest. Aspulvinone H exhibits antibacterial activity against Staphylococcus aureus. Aspulvinone H inhibits the growth of pancreatic ductal adenocarcinoma xenografts. Aspulvinone H reduces postprandial blood glucose in mice. Aspulvinone H can be used in research related to pancreatic ductal adenocarcinoma, diabetes, and Staphylococcus aureus infection .
loading...
    loading...